Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Preetesh JainHagop M KantarjianAhmad GhorabKoiji SasakiElias J JabbourGraciela Nogueras GonzalezRashmi Kanagal-ShamanaGhayas C IssaGuillermo Garcia-ManeroDevendra KcSara DellasalaSherry PierceMarina KonoplevaWilliam G WierdaSrdan VerstovsekNaval G DaverTapan Mahendra KadiaGautam BorthakurSusan M O'BrienZeev EstrovFarhad RavandiJorge E CortesPublished in: Cancer (2017)
Patients with CML-BP continue to pose a therapeutic challenge, have dismal outcomes, and require newer treatment approaches. Cancer 2017;123:4391-402. © 2017 American Cancer Society.